Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HX97
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 9 | 13 | PF00656 | 0.726 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.483 |
CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.255 |
CLV_PCSK_FUR_1 | 186 | 190 | PF00082 | 0.474 |
CLV_PCSK_KEX2_1 | 186 | 188 | PF00082 | 0.535 |
CLV_PCSK_KEX2_1 | 70 | 72 | PF00082 | 0.256 |
CLV_PCSK_PC1ET2_1 | 188 | 190 | PF00082 | 0.569 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.248 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.592 |
DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.567 |
DOC_USP7_MATH_1 | 192 | 196 | PF00917 | 0.475 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.666 |
LIG_14-3-3_CanoR_1 | 70 | 76 | PF00244 | 0.556 |
LIG_14-3-3_CanoR_1 | 91 | 101 | PF00244 | 0.549 |
LIG_BIR_III_4 | 138 | 142 | PF00653 | 0.462 |
LIG_Clathr_ClatBox_1 | 53 | 57 | PF01394 | 0.446 |
LIG_FHA_1 | 109 | 115 | PF00498 | 0.588 |
LIG_FHA_1 | 143 | 149 | PF00498 | 0.647 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.624 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.521 |
LIG_LIR_Gen_1 | 162 | 171 | PF02991 | 0.565 |
LIG_LIR_Gen_1 | 57 | 68 | PF02991 | 0.530 |
LIG_Pex14_2 | 132 | 136 | PF04695 | 0.530 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.435 |
MOD_CK1_1 | 11 | 17 | PF00069 | 0.620 |
MOD_CK1_1 | 149 | 155 | PF00069 | 0.622 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.447 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.518 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.546 |
MOD_CK2_1 | 83 | 89 | PF00069 | 0.459 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.615 |
MOD_GlcNHglycan | 154 | 157 | PF01048 | 0.478 |
MOD_GlcNHglycan | 194 | 197 | PF01048 | 0.718 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.733 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.494 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.698 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.598 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.528 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.548 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.555 |
MOD_NEK2_1 | 92 | 97 | PF00069 | 0.595 |
MOD_PIKK_1 | 83 | 89 | PF00454 | 0.459 |
MOD_PK_1 | 127 | 133 | PF00069 | 0.410 |
MOD_Plk_1 | 162 | 168 | PF00069 | 0.370 |
MOD_Plk_4 | 121 | 127 | PF00069 | 0.451 |
TRG_DiLeu_BaLyEn_6 | 88 | 93 | PF01217 | 0.450 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.530 |
TRG_ER_diArg_1 | 116 | 119 | PF00400 | 0.450 |
TRG_ER_diArg_1 | 180 | 183 | PF00400 | 0.507 |
TRG_ER_diArg_1 | 186 | 189 | PF00400 | 0.505 |
TRG_ER_diArg_1 | 69 | 71 | PF00400 | 0.521 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HUV2 | Leptomonas seymouri | 49% | 78% |
A0A1X0NSZ2 | Trypanosomatidae | 35% | 91% |
A0A3S7WUC9 | Leishmania donovani | 100% | 100% |
A0A422N3W3 | Trypanosoma rangeli | 37% | 76% |
A4H8X3 | Leishmania braziliensis | 75% | 100% |
C9ZTX0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 99% |
E9AQZ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4QEG4 | Leishmania major | 93% | 100% |
V5BH99 | Trypanosoma cruzi | 36% | 94% |